Perspective Therapeutics (CATX) Work In Process (2011 - 2023)
Perspective Therapeutics (CATX) reported Work In Process of $616000.0 for Q1 2023, up 73.52% on a YoY basis from $355000.0 in Q1 2022, and down 3.14% sequentially from $636000.0 in Q4 2022.
Perspective Therapeutics (CATX) Work In Process (2011 - 2023) Analysis & Trends
Perspective Therapeutics (CATX) has 11 years of Work In Process data on file, last reported at $616000.0 in Q1 2023.
- For the quarter ending Q1 2023, Work In Process rose 73.52% year-over-year to $616000.0; the trailing twelve-month figure through Mar 2023 stood at $616000.0 (up 73.52% YoY), and the FY2022 full-year result was $636000.0, changed N/A from the prior year.
- Work In Process fell to $616000.0 in Q1 2023, from $636000.0 in the prior quarter.
- In the past five years, Work In Process ranged from a high of $636000.0 in Q4 2022 to a low of $114000.0 in Q1 2019.
- A 5-year average of $306000.0 and a median of $240000.0 in 2020 frame the typical range for Work In Process.
- Across the five-year window, Work In Process retreated 25.49% in 2019 and surged 129.1% in 2022, its largest moves.
- Tracing CATX's Work In Process over 5 years: stood at $166000.0 in 2019, then advanced by 26.51% to $210000.0 in 2020, then surged by 37.14% to $288000.0 in 2021, then soared by 120.83% to $636000.0 in 2022, then dropped by 3.14% to $616000.0 in 2023.
- Business Quant data shows CATX's Work In Process at $616000.0 in Q1 2023, $636000.0 in Q4 2022, and $614000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Perspective Therapeutics | 294.24 Mn | 294.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 616,000.00 |
| Dec 31, 2022 | 636,000.00 |
| Sep 30, 2022 | 614,000.00 |
| Jun 30, 2022 | 462,000.00 |
| Mar 31, 2022 | 355,000.00 |
| Dec 31, 2021 | 288,000.00 |
| Sep 30, 2021 | 268,000.00 |
| Jun 30, 2021 | 286,000.00 |
| Mar 31, 2021 | 201,000.00 |
| Dec 31, 2020 | 210,000.00 |
| Sep 30, 2020 | 240,000.00 |
| Jun 30, 2020 | 221,000.00 |
| Mar 31, 2020 | 198,000.00 |
| Dec 31, 2019 | 166,000.00 |
| Sep 30, 2019 | 161,000.00 |
| Jun 30, 2019 | 166,000.00 |
| Mar 31, 2019 | 114,000.00 |
| Dec 31, 2018 | 97,000.00 |
| Sep 30, 2018 | 102,000.00 |
| Jun 30, 2018 | 96,000.00 |